This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by García-Piñeres, A. J. Articles by Pinto, L. A. Search for Related Content PubMed PubMed Citation Articles by García-Piñeres, A. J. Articles by Pinto, L. A.

Persistent Human Papillomavirus Infection Is Associated with a Generalized Decrease in Immune Responsiveness in Older Women

¹ HPV Immunology Laboratory, Science Applications International Corporation-Frederick, Inc./National Cancer Institute-Frederick, Frederick, Maryland; ² Division of Cancer Epidemiology and Genetics and ³ Vaccine Branch, Center for Cancer Research, National Cancer Institute, NIH; ⁴ Medical Research Solutions, Bethesda, Maryland; ⁵ Proyecto Epidemiológico Guanacaste; ⁶ Centro de Investigación en Estructuras Microscópicas and Centro de Investiagación en Biología Celular y Molecular, University of Costa Rica, San José, Costa Rica; and ⁷ Albert Einstein College of Medicine, Bronx, New York

Requests for reprints: Ligia A. Pinto, HPV Immunology Laboratory, National Cancer Institute-Frederick/Science Applications International Corporation-Frederick, Inc., Building 469, Room 120, Frederick, MD 21702. Phone: 301-846-1766; Fax: 301-846-6954; E-mail: lpinto{at}ncifcrf.gov.

The development of cervical cancer and its precursors are linked to persistent infection with oncogenic types of human papillomavirus (HPV). Host immune responses seem to be determinants of risk for this disease. However, little is known about the immunologic determinants of HPV persistence. Here, we examined the association between lymphoproliferative responses to antigens/mitogens and persistent HPV infection in women older than 45 years. Women included in this study were participants in a 10,000-woman population-based cohort study of cervical neoplasia in Costa Rica. Women older than 45 years and HPV DNA positive at a screening visit were selected as cases (n = 283). We selected a comparably sized control group of HPV DNA–negative women, matched to cases on age and time since enrollment (n = 261). At an additional clinical visit, women were cytologically and virologically rescreened, and cervical and blood specimens were collected. Proliferative responses to phytohemagglutinin (PHA), influenza virus (Flu), and HPV16 virus-like particle (VLP) were lower among women with persistent HPV infection [median counts per minute (cpm): 72,849 for PHA, 1,241 for Flu, and 727 for VLP] than for the control group (median cpm: 107,049 for PHA, 2,111 for Flu, and 2,068 for VLP). The decreases were most profound in women with long-term persistence and were only observed for the oldest age group (65 years). Our results indicate that an impairment in host immunologic responses is associated to persistent HPV infection. The fact that effects were evident for all studied stimuli is suggestive of a generalized effect. (Cancer Res 2006; 66(22): 11070-6)